HR 10369
Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026
HR 10369 (119th Congress) is federal legislation introduced in the U.S. House of Representatives on September 14, 2026.
Current status: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (2026-09-14).
Summary
Sponsors
Latest Action
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2026-09-14